Molecular Pathways: Next-Generation Immunotherapy—Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
Year: 2012
Type: article
Source: Clinical Cancer Research
Institutions: Dana-Farber Cancer Institute, Stanford University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Genentech
OpenAlex ID: W2122495232
